A Questionnaire-Based Survey on the Prescription of Non-Steroidal Anti-Inflammatory Drugs by Physicians in East Asian Countries in 2007
暂无分享,去创建一个
A. Terano | K. Hahm | T. Joh | Y. Naito | Y. Fujiwara | T. Arakawa | Y. Kinoshita | K. Takeuchi | H. Yamagami | U. Kachintorn | K. Furuta | J. Sollano | Qi Zhu | A. A. Rani | S. Takahashi | T. Matsumoto | Eun Jung Jang | N. Agustanti | Huifang Xiong | Xi Chen
[1] F. Chan,et al. Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents , 2008, The American Journal of Gastroenterology.
[2] K. Haruma,et al. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future , 2008, Journal of Gastroenterology.
[3] Zhaoshen Li,et al. Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial—STORM STUDY , 2007, Journal of clinical biochemistry and nutrition.
[4] T Rokkas,et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report , 2006, Gut.
[5] P. McGettigan,et al. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. , 2006, JAMA.
[6] K. Sugano,et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan , 2006, European Journal of Clinical Pharmacology.
[7] J. Emberson,et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials , 2006, BMJ : British Medical Journal.
[8] T. Yoshikawa,et al. 15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New Applications , 2005, Digestive diseases and sciences.
[9] T. Schnitzer,et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial , 2004, The Lancet.
[10] L. Laine,et al. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. , 2004, Gastroenterology.
[11] P Tugwell,et al. Prevention of NSAID-induced gastroduodenal ulcers. , 2002, The Cochrane database of systematic reviews.
[12] F. Chan,et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. , 2001, The New England journal of medicine.
[13] Y. Loke,et al. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis , 2000, BMJ : British Medical Journal.
[14] S. Hernández-Díaz,et al. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.
[15] F. Chan,et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers , 1997, The Lancet.
[16] S. Gabriel,et al. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.
[17] L. G. García Rodríguez,et al. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. , 2007, Gastroenterology.
[18] Y. Fujiwara,et al. Prostaglandins in the stomach: an update. , 1998, Journal of clinical gastroenterology.